The Alternative Heart: Impact of Alternative Splicing in Heart Disease

被引:70
|
作者
Lara-Pezzi, Enrique [1 ]
Gomez-Salinero, Jesus [1 ]
Gatto, Alberto [1 ]
Garcia-Pavia, Pablo [2 ]
机构
[1] Ctr Nacl Invest Cardiovasc, Cardiovasc Dev & Repair Dept, Madrid 28029, Spain
[2] Hosp Univ Puerta Hierro Majadahonda, Dept Cardiol, Madrid, Spain
关键词
Alternative splicing; Molecular cardiology; Sarcomere; Cell signalling; Ion channels; Antisense oligonucleotides; CARDIAC TROPONIN-T; PRE-MESSENGER-RNA; UNFOLDED PROTEIN RESPONSE; BINDING-PROTEIN; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; MYOTONIC-DYSTROPHY; PASSIVE STIFFNESS; ALPHA-TROPOMYOSIN; CHLORIDE CHANNEL;
D O I
10.1007/s12265-013-9482-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alternative splicing is the main driver of protein diversity and allows the production of different proteins from each gene in the genome. Changes in exon exclusion, intron retention or the use of alternative splice sites can alter protein structure, localisation, regulation and function. In the heart, alternative splicing of sarcomeric genes, ion channels and cell signalling proteins can lead to cardiomyopathies, arrhythmias and other pathologies. Also, a number of inherited conditions and heart-related diseases develop as a result of mutations affecting splicing. Here, we review the impact that changes in alternative splicing have on individual genes and on whole biological processes associated with heart disease. We also discuss promising therapeutic tools based on the manipulation of alternative splicing.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 50 条
  • [21] Protein Kinase C regulates alternative splicing transitions during heart development
    Verma, Sunil K.
    Deshmukh, Vaibhav
    Kuyumcu-Martinez, Muge N.
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [22] Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
    Dhir, Ashish
    Buratti, Emanuele
    FEBS JOURNAL, 2010, 277 (04) : 841 - 855
  • [23] Alternative Splicing as a Target for Cancer Treatment
    Martinez-Montiel, Nancy
    Rosas-Murrieta, Nora Hilda
    Anaya Ruiz, Maricruz
    Monjaraz-Guzman, Eduardo
    Martinez-Contreras, Rebeca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [24] Significance of alternative splicing in cancer cells
    Qi, Fei
    Li, Yong
    Yang, Xue
    Wu, Yan-Ping
    Lin, Lian-Jun
    Liu, Xin-Min
    CHINESE MEDICAL JOURNAL, 2020, 133 (02) : 221 - 228
  • [25] Aberrant alternative splicing in breast cancer
    Yang, Quan
    Zhao, Jinyao
    Zhang, Wenjing
    Chen, Dan
    Wang, Yang
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (10) : 920 - 929
  • [26] Functional roles of alternative splicing factors in human disease
    Cieply, Benjamin
    Carstens, Russ P.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2015, 6 (03) : 311 - 326
  • [27] Computation-assisted targeted proteomics of alternative splicing protein isoforms in the human heart
    Han, Yu
    Wood, Silas D.
    Wright, Julianna M.
    Dostal, Vishantie
    Lau, Edward
    Lam, Maggie P. Y.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 154 : 92 - 96
  • [28] Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects
    Mehta, Zubin
    Touma, Marlin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [29] Transcriptomic Alterations in Spliceosome Components in Advanced Heart Failure: Status of Cardiac-Specific Alternative Splicing Factors
    Gimenez-Escamilla, Isaac
    Perez-Carrillo, Lorena
    Gonzalez-Torrent, Irene
    Delgado-Arija, Marta
    Benedicto, Carlota
    Portoles, Manuel
    Tarazon, Estefania
    Rosello-Lleti, Esther
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [30] Alternative transcription and alternative splicing in cancer
    Pal, Sharmistha
    Gupta, Ravi
    Davuluri, Ramana V.
    PHARMACOLOGY & THERAPEUTICS, 2012, 136 (03) : 283 - 294